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Resumen
Objetivo: modificar el cuestionario de síntomas neurotóxicos (Q16) y evaluar su repetibilidad y
comparabilidad. Metodología: un grupo de cien participantes entre los dieciocho y los cuarenta
años con un nivel educativo equivalente a bachillerato o formación técnica, aproximadamente
similar al nivel de educación de los trabajadores de lavandería de Bogotá, fue empleado para validar el cuestionario en Sídney, Australia. Tres cuestionarios y uno sobre información demográfica
fueron aplicados a los participantes. El cuestionario Q16 modificado fue aplicado dos veces para
evaluar su repetibilidad. Resultados: sesenta hombres y cuarenta mujeres participaron en el estudio.
Para analizar la confiabilidad del cuestionario Q16 modificado fue aplicado el Alfa de Cronbach,
obteniéndose un coeficiente de consistencia interna alfa de 0,887. Para evaluar la repetibiliad Se
aplicó el test de t pareada, obteniéndose diferencias significativas en dos preguntas con valores
p = 0,027 y p = 0,020, respectivamente. Comparando los resultados de la escala de Likert con el
original se observaron relaciones directas entre los mismos. Conclusiones: el cuestionario modificado Q16 brinda más opciones de respuesta con mayor acercamiento a la realidad, consistencia
interna y repetibilidad. El cuestionario modificado Q16 puede ser una mejor opción para evaluar
los síntomas neurotóxicos.
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Abstract
Objective: To modify the neurotoxic symptoms questionnaire (Q16) and assess its repeatability and
comparability. Materials and Methods: A group of 100 participants ranging from the ages of 18 to
40, with an education level equivalent to high school or technical college, similar to the education
level of dry-cleaners in Bogotá was used to validate the questionnaire in Sydney, Australia. Three
test questionnaires and a demographic information questionnaire were presented to participants.
The modified Q16 was applied twice in order to evaluate repeatability. Results: Sixty males and
forty females participated in the study. Cronbach’s Alpha was applied in order to analyze the
reliability of the Q16 modified with a Likert scale, getting an internal consistency of 0.887. The
paired t test was applied in order to evaluate repeatability, obtaining significant differences in two
questions with p=0.027 and p=0.020 values, respectively. Comparing the results of the Likert scale
scores with the original, a direct link was observed between them. Conclusions: The modified
Q16 provides more answer choices, closer to reality, internal consistency and repeatability. The
modified Q16 may be a better option to assess neurological symptoms.

* Docente Investigadora, Universidad de La Salle, Bogotá-Colombia. Candidata a PhD en Optometría, University of New South Wales,
Sídney-Australia. Becaria Colciencias-Laspau, Universidad de La Salle.
** Bachelor Sc (Hons), PhD. The University of New South Wales.
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Introducción
Los solventes orgánicos pueden causar depresión
del sistema nervioso central (SNC) (World Health
Organization, 1985; Candura, 1991; Cherry et ál.,
1980; Xintaras et ál., 1984; Anger et ál., 1999), por
lo tanto, la evaluación de síntomas neurológicos
es importante en la prevención de enfermedades
neurológicas agudas y crónicas.
Cuestionarios de tamizaje (Q16, entre otros) pueden tener resultados positivos de diferentes maneras. Por ejemplo, con el cuestionario Q16 se puede
facilitar la detección temprana de personas que
sufren efectos a causa de su exposición a solventes
orgánicos. Así, esta intervención puede ser hecha
para reducir o eliminar su exposición a solventes
o recibir tratamiento cuando otros factores fueren la causa del problema. El cuestionario Q16
contiene dieciséis preguntas validadas acerca de
síntomas de neurotoxicidad (Hogstedt et ál., 1984).
La comprensión de las preguntas fue investigada
por médicos y psicólogos. La confiabilidad fue
evaluada realizando procedimientos de prueba
y reprueba. La validez fue evaluada investigando
el poder de las preguntas o discriminando entre
grupos de expuestos y no expuestos, además, por la
comparación de grupos con y sin “síndrome psicoorgánico”. El estudio sugiere realizar valoraciones
médicas cuando cuatro o más síntomas son reportados por jóvenes de hasta veintiocho años de edad
o cuando seis o más síntomas son reportados por
mayores de veintiocho años (Hogstedt et ál., 1984).
Lundberg et ál. (1997) aplicaron el cuestionario
Q16 para analizar síntomas neurotóxicos presentes
en trabajadores expuestos a solventes orgánicos. Este cuestionario fue útil para realizar comparación
de grupos con diferentes exposiciones a solventes
orgánicos. La prevalencia de personas con más de
seis síntomas en el cuestionario Q16 se relaciona
con el incremento acumulativo por exposición a
solventes. El estudio sugiere que el cuestionario
es un instrumento sensible para detectar grupos
con alta exposición a solventes orgánicos, así como
por exposición previa. El cuestionario Q16 ha sido

traducido y validado en diferentes idiomas, como
alemán, francés, noruego y español (Rodezno et
ál., 1995; Lundberg et ál., 1997; Ihrig et ál., 2003;
Dick, 2006).

Materiales y métodos
El cuestionario Q16 (versiones en inglés y español)
provee opciones de respuestas de sí/no, siendo las
respuestas de los individuos no muy claras. Como
se buscaba una mayor precisión en las respuestas
de los participantes, se consideró modificar el cuestionario Q16 de la forma binaria de repuesta (sí/
no) a respuestas considerando la escala de Likert
(con 5 niveles de respuesta) y evaluar su repetibilidad. Esta investigación fue aprobada por el comité
de ética de la Universidad de New South Wales
obteniéndose aprobación número 1006 antes de
que el reclutamiento de sujetos iniciara. Cada
participante emitió su consentimiento informado
por escrito antes después de que los riesgos y beneficios del estudio y los procedimientos fueran
ampliamente explicados.
Muestra
Un grupo de cien participantes entre dieciocho
y cuarenta años de edad con nivel educativo de
bachillerato o formación técnica quienes tuvieran
trabajos del mismo nivel que un trabajador de lavandería de Bogotá, fueron reclutados para aplicar
y probar el cuestionario en Sídney, Australia.
El procesamiento de reclutamiento de sujetos
de investigación fue el siguiente: una carta fue
enviada al Consejero de Recursos Humanos de
The University of New South Wales solicitando
su colaboración para dar a conocer la necesidad
de contar con voluntarios para la investigación,
procedentes del grupo de servicios generales, quienes cumplieran con el nivel educativo. A las personas interesadas se les solicitaba contactar a los
investigadores directamente por teléfono o correo
electrónico para obtener los cuestionarios. Además,
amigos de estos participantes podían ser también
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Respuestas cuestionario modificado
con escala de Likert, primera medición

Método

Se utilizó el paquete estadístico SPSS© (versión
18.0) para analizar los datos recolectados. Para analizar la confiabilidad del cuestionario modificado
Q16 utilizando la escala de Likert, fue aplicado el
Alfa de Cronbach (ver tabla 1).

Tres cuestionarios a evaluar (ver apéndice A) y un
cuestionario sobre información demográfica (ver
apéndice B) fueron enviados a los participantes.
Primero, se les solicitó brindar su información demográfica y de salud general. Luego se les solicitó
completar los cuestionarios 1 y 2 el día en que los
recibían y el cuestionario 3 debería ser diligenciado
una semana después. Entonces, los tres cuestionarios, una vez diligenciados, más el de información
demográfica debían ser devueltos al investigador.
Se diseñó una guía con las instrucciones sobre
cómo diligenciar los cuestionarios para ayudar al
participante a entender la metodología y además
se le solicitó seguir los pasos establecidos ordenadamente. El primer cuestionario era el cuestionario modificado Q16, el segundo cuestionario era
el original Q16 y el tercero era de nuevo el Q16
modificado. El cuestionario Q16 modificado fue
aplicado dos veces para evaluar su repetividad.

Resultados
Caracterización de la muestra
El grupo participante de la investigación estaba
constituido por sesenta hombres y cuarenta mujeres. El 29% se encontraba entre los veintitrés y
los veintisiete años; 28%, entre los veintiocho y los
32, y 24%, entre los 33 y los 37 años.

tabla 1. Resultados Alfa de Cronbach para la escala de Likert
Alpha de
Cronbach

Alpha de Chronbach Basado en

0,887

0,889

ítems estándar

Nº de ítems
16

Fuente: elaboración propia
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incluidos, siempre y cuando cumplieran con el
criterio de inclusión.

El coeficiente alfa para 16 preguntas es de 0,887,
lo que muestra una alta consistencia interna (teniendo en cuenta que un coeficiente de confiabilidad superior a 0,70 se considera aceptable para
investigaciones).
La prueba t pareada fue aplicada para analizar las
diferencias entre la primera y segunda medición
de la versión modificada del Q16. La pregunta
número 15 (“Siento que tengo menos sensibilidad
o una completa pérdida de sensibilidad en algunas
partes de mis brazos o piernas”) y la pregunta 16
(“A menudo me despierto y tengo problemas para
volver a dormir de nuevo”) presentaron diferencias
significativas, p = 0,03 y p = 0,02, respectivamente.
Estos resultados muestran que la escala de Likert
utilizada en la modificación del cuestionario Q16
es repetible y da confiabilidad al cuestionario
(tabla 2).
Comparación entre las respuestas
binarias (sí/no) en el cuestionario Q16
original y el Q16 modificado

Información demográfica
Un sujeto reportó sufrir diabetes; uno, hipertensión;
cinco, cáncer; dos, enfermedades neurológicas,
como epilepsia, y diecinueve personas, ansiedad.
El 20% eran fumadores; 54% eran consumidores
de bebidas alcohólicas. El 13% tomaba medicamentos por problemas como alergias, infecciones
e inflamación.

Para analizar los datos recolectados fue utilizado
el paquete estadístico SPSS© (versión 18.0). Para
conocer la relación existente entre las respuestas
dadas en el cuestionario original Q16 y compararlas con las respuestas dadas al Q16 modificado se utilizó el análisis descriptivo del programa
SPSS.
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tabla 2. Resultados prueba t pareada
Paired differences
Mean

Std. deviation

Std. error mean

Pair 1 LiQ1 - LisecQ1

0,040

0,549

Pair 2 LiQ2 - LicsecQ2

0,070

Pair 3 LiQ3 - LicsecQ3

95% confidence interval of the difference

t

df

Sig.
(2-tailed)

Lower

Upper

0,055

-0,069

0,149

0,729

99

0,468

0,432

0,043

-0,016

0,156

1,619

99

0,109

-0,050

0,411

0,041

-0,132

0,032

-1,216

99

0,227

Pair 4 LiQ4 - LicsecQ4

-0,040

0,567

0,057

-0,153

0,073

-0,705

99

0,482

Pair 5 LiQ5 - LicsecQ5

0,010

0,577

0,058

-0,105

0,125

0,173

99

0,863

Pair 6 LiQ6 - LicsecQ6

-0,060

0,397

0,040

-0,139

0,019

-1,510

99

0,134

Pair 7 LiQ7 - LicsecQ7

-0,030

0,540

0,054

-0,137

0,077

-0,555

99

0,580

Pair 8 LiQ8 - LicsecQ8

0,090

0,514

0,051

-0,012

0,192

1,75

99

0,083

Pair 9 LiQ9 - LicsecQ9

0,070

0,590

0,059

-0,047

0,187

1,186

99

0,239

Pair 10 LiQ10 - LicsecQ10

0,060

0,633

0,063

-0,066

0,186

0,948

99

0,345

Pair 11 LiQ11 - LisecQ11

0,040

0,511

0,051

-0,061

0,141

0,783

99

0,436

Pair 12 LiQ12 - LicsecQ12

0,020

0,402

0,040

-0,060

0,100

0,498

99

0,620

Pair 13 LiQ13 - LicsecQ13

-0,030

0,332

0,033

-0,096

0,036

-0,904

99

0,368

Pair 14 LiQ14 - LicsecQ14

-0,010

0,522

0,052

-0,114

0,094

-0,192

99

0,849

Pair 15 LiQ15 - LicsecQ15

-0,110

0,490

0,049

-0,207

-0,013

-2,244

99

0,027

Pair 16 LiQ16 - LicsecQ16

-0,160

0,677

0,068

-0,294

-0,026

-2,362

99

0,020

Fuente: elaboración propia

Considerando los puntajes de la escala de Likert: 1
(totalmente en desacuerdo), 2 (en desacuerdo), 3
(neutral), 4 (de acuerdo), 5 (totalmente de acuerdo), y la relación con las respuestas positivas (sí) o
negativas (no), los resultados muestran que cuando
una persona responde “sí” el puntaje se encuentra entre el valor de 3 (neutral), 4 (de acuerdo) y
5 (totalmente de acuerdo). Mientras que cuando una persona responde “no”, la tendencia del
puntaje es hacia 1 (totalmente en desacuerdo) o
2 (en desacuerdo). No obstante, un par de casos
(n = 2) mostraron un comportamiento inverso. Se
puede decir que quizás estos dos participantes
estaban distraídos cuando respondieron los cuestionarios.
La tendencia muestra que los sujetos pueden encontrar más fácil el uso de la escala de Likert con
más opciones de respuesta que si ellos debieran
forzar sus respuestas y ajustarlas dentro de dos
opciones, en este caso, “sí” o “no”.

Por lo tanto, considerando estas comparaciones y
los análisis estadísticos, se puede considerar que
la versión modificada del cuestionario Q16 puede
brindar mayor información acerca de la evaluación
de síntomas neurotóxicos.

Discusión
Teniendo en cuenta los resultados del cuestionario modificado Q16, y comparándolos con los
del original (Lundberg et ál., 1997), la escala de
Likert puede ser considerada como una buena
herramienta para medir y comparar síntomas reportados sobre una serie de preguntas afirmativas
con mayor precisión que con tipos de respuesta
sí/no, y aun mayor facilidad de evaluación con
preguntas cerradas (Shank y Bircher, 2009).
Forzar artificialmente las respuestas entre un formato sí/no puede reducir las diferencias indivi-
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sujetos más opciones para expresar sus sentimientos y brindar mayor acercamiento a la realidad,
consistencia interna y repetibilidad.
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duales, hacer que se pierda la fuerza de lo que se
cree (ser débil al responder), introducir errores
sistemáticos y cohibir a los sujetos para responder
lo que ellos originalmente desearían (Chandler y
Patterson, 1976).
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Apéndice A t1
DATE OF COMPLETION__________________________ ID Number_____________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 – NUMBER 1
S cale
Nº

Statement

Strongly
disagree

1

I have a short memory

2

My relatives and/or friends have told me that I am forgetful

3

I forget activities that I consider important

4

I generally find it hard to get the meaning of the news, programs, or fiction series
that I watch on TV or listen to on the radio

5

I have problems with concentrating

6

I often feel irritated without any reason

7

I often feel depressed or sad without any particular reason

8

I have problems deciding to do activities I know I must do

9

I feel abnormally tired

10

Sometimes I feel an oppression of my chest

11

I have had a sudden sensation of falling down while standing or walking

12

I often have a painful tingling in some part of my body

13

I have problems with buttoning or unbuttoning my clothes

14

I feel that I have lost strength in my arms or legs

15

I feel that I have less sensitivity or a complete loss of sensitivity in some parts of my
arms or legs

16

I often wake up and then have problems getting back to sleep again

Disagree

Neutral

Agree

Strongly
agree

Modificación del cuestionario de síntomas neurotóxicos (Q16)
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DATE OF COMPLETION__________________________ ID Number_________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 –NUMBER 2
N°

Question

S cale
Y es

1

Do you have a short memory?

2

Have your relatives and/or friends have told you that you are forgetful?

3

Do you often forget activities that you consider important?

4

Do you generally find it hard to get the meaning of the news, programs, or fiction series that I watch on TV or listen to on the radio?

5

Do you have problems with concentrating?

6

Do you often feel irritated without any reason?

7

Do you often feel depressed or sad without any particular reason

8

Do you have problems deciding to do activities I know you must do?

9

Are you abnormally tired?

10

Do you sometimes feel an oppression of your chest?

11

Have you had a sudden sensation of falling down while standing or walking?

12

Do you often have a painful tingling in some part of your body?

13

Do you have problems with buttoning or unbuttoning your clothes

14

Do you feel that I have lost strength in my arms or legs?

15

Do you feel less sensitivity or a complete loss of sensitivity in some parts of your arms or legs?

16

Do you often wake up and then have problems getting back to sleep again?
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No

DATE OF COMPLETION__________________________ ID Number_____________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 – NUMBER 3
SCALE
Nº

Statement

Strongly
Disagree

1

I have a short memory

2

My relatives and/or friends have told me that I am forgetful

3

I forget activities that I consider important

4

I generally find it hard to get the meaning of the news, programs, or fiction series that
I watch on TV or listen to on the radio

5

I have problems with concentrating

6

I often feel irritated without any reason

7

I often feel depressed or sad without any particular reason

8

I have problems deciding to do activities I know I must do

9

I feel abnormally tired

10

Sometimes I feel an oppression of my chest

11

I have had a sudden sensation of falling down while standing or walking

12

I often have a painful tingling in some part of my body

13

I have problems with buttoning or unbuttoning my clothes

14

I feel that I have lost strength in my arms or legs

15

I feel that I have less sensitivity or a complete loss of sensitivity in some parts of my
arms or legs

16

I often wake up and then have problems getting back to sleep again

Disagree

Neutral

Agree

Strongly
Agree

Modificación del cuestionario de síntomas neurotóxicos (Q16)
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Apéndice B
Demographic information
Q1: Age (years):
 18 – 22  23 – 27
 28– 32
 33 – 37
 38– 42
 38-40
Q2: Gender:
 Male
 Female
Q3: Do you suffer from Diabetes?
 No
 Yes
Q4: Do you suffer from Hypertension?
 No
 Yes
Q5: Do you suffer from cancer?
 Yes
 No
Q6: Do you suffer from any neurological disease? Please if yes, state the
name of the disease.
 No
 Yes
Name of the disease:__________________________________
Q7: Do you suffer of anxiety or depression?
 No
 Yes
Q8: Do you smoke? if yes, answer question number 9
 No
 Yes

Q9-: How many cigarettes you smoke per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q10-: How many cigars you smoke per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q11: Do you drink alcohol? if yes, answer question number 13
 No
 Yes
Q12-: How many alcoholic drinks you drink per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q13: Do you take medication? If yes, answer question number 15
 No
 Yes
Q14-: What it is for?
 Infections
 Diabetes
 Hypertension
 Allergies
 AINES
 Corticoids
 Other (Specify) _______________________

DATE OF COMPLETION_______________________ID Number_______________
Baseline Survey

DEMOGRAPHIC AND GENERAL HEALTH INFORMATION: Please tell us some basic information about yourself
Este aparte es directamente al comienzo de la encuesta de base, no al final como aparece aquí.
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Modificación del cuestionario de síntomas neurotóxicos (Q16)

Introduction
Organic solvents can cause depression in the CNS
(Central Nervous System) (World Health Organization, 1985) (Candura, 1991) (Cherry, Waldron
et al., 1980; Xintaras, Johnson et al., 1984; Anger,
Rohlman et al., 1999). As a result, evaluating neurological symptoms is important to prevent acute
and chronic neurological diseases.
Questionnaire screening (e.g. Q16) may result in
several positive effects. For instance, screening with
a Q16 questionnaire can facilitate early detection
of individuals suffering organic solvent related effects, so that intervention can be made to reduce
or eliminate their exposure to solvents or receive
treatment when other factors are the cause of their
distress. The Q16 contains 16 validated questions
regarding symptoms of neurotoxicity (Hogstedt
et al., 1984). The understanding of the questions
was investigated by physicians, psychologists, and
workers. Reliability was studied by test-retest procedures. Validity was evaluated by investigating the
power of the questions to discriminate between
exposed and non-exposed groups and by comparisons of groups with and without a “psycho-organic
syndrome”. Further evaluation is indicated when
four or more symptoms are reported by people
younger than 28 years of age or when six or more
symptoms are reported by those older than 28
(Hogstedt et al., 1984).
Lundberg et al. (1997) applied the Q16 questionnaire to analyse neurotoxic symptoms that may be
present in workers exposed to organic solvents.
This questionnaire was useful for comparison

 etween groups with different exposures to organic
b
solvents. The prevalence of people with more than
six symptoms in the Q16 questionnaire rose with
an increasing cumulative exposure to solvents. The
study suggests that the questionnaire is a sensitive
instrument to detect groups with high exposure to
organic solvents among currently, as well as previously exposed workers. The Q16 questionnaire has
been translated and validated to different languages
such as German, French, Norwegian and Spanish
(Rodezno, Lundberg et al., 1995; Lundberg, 1997;
Ihrig, 2003; Dick, 2006).

Materials and Methods
The Q16 questionnaire (Spanish and English
versions) provides a yes/no response option to
questions whereas answers by individuals may not
be clear. Since we are looking for more precision
in the participants’ answers, it was considered
to change the Q16 questionnaire from a binary
(yes/no) response to a Likert response scale (with
5 levels) and to assess its repeatability. This study
was approved by the University of New South
Wales Human Research Ethics Advisory Panel
(HREA, approval number 1006) before recruitment commenced. Each subject provided written,
informed consent before taking part in the study
after the risks and benefits of study procedures had
been fully explained.
Design
A group of 100 participants between 18-40 years
of age, with an education level of high school
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or technical college who were designed to have
the same job level as dry-cleaners in Bogotá, was
recruited to test and validate the questionnaire in
Sydney, Australia.
Recruitment procedure was as follows: A letter was
sent to the Human Resources Consultant of the
University of New South Wales asking for their
assistance to advertise and circulate our call for
volunteers to Facilities Management staff, who
generally hand the target level of education. Interested people were requested to contact the researchers directly by telephone or email in order
to obtain the questionnaires. Moreover, friends
of participants could also be recruited if they met
the inclusion criteria.
Method
Three test questionnaires (see appendix A) and a
demographic questionnaire (see appendix B) were
supplied to participants. Firstly, they were asked
to provide demographic information about their
general health. Then they were asked to complete
questionnaires 1 and 2 on the day they receive it
and questionnaire 3 about one week later, and then
to send all 3 questionnaires plus the demographic
information back to the researcher. Instructions
were designed to help the participant to understand
the methodology and what they were required to
do step-by-step. The first questionnaire was the
modified Q16, the second was the original version
and the third was the modified Q16. The modified Q16 was applied twice in order to evaluate
its repeatability.

Results
Characterization Sample
The group that agreed to participate in this study
was composed of 60 males and 40 females. Twentynine percent (29%) of them were 23-27 years old,
28% were 28-32 and 24% 33-37 years old.

Demographic Information Results
One subject self reported suffering from diabetes; one from hypertension; five from cancer; two
from neurological diseases such as epilepsy and
19 from anxiety.
Twenty percent (20%) of them were smokers; fiftyfour percent (54%) were alcohol consumers. Thirteen percent (13%) took medication for problems
such as allergies, infections and inflammation.
Questionnaire Answers Modified with
Likert Scale, First Measure to Second
Measure
The SPSS© statistical package (version 18.0) was
used to analyse the data collected. Cronbach’s Alpha was applied in order to analyse the reliability of
the Q16 modified with a Likert scale (see Table 1).
table 1. Cronbach’s Alpha Results for Likert scale
Alpha de
Cronbach

Cronbach’s Alpha de Chronbach
Basado en ítems estándar

Nº de ítems

0,887

0,889

16

Source: Own elaboration

The alpha coefficient for the sixteen items is 0.887,
suggesting that the items have a relatively high internal consistency (note that a reliability coefficient
of 0.70 or higher is considered to be “acceptable”
in research situations).
The paired t test was applied to check for differences between the first measure and second measure with the modified Q16. Questions number
15 (I feel that I have less sensitivity or a complete
loss of sensitivity in some parts of my arms or legs)
and 16 (I often wake up and then have problems
getting back to sleep again) showed significant differences of (p = 0.03) and (p = 0.02) respectively
(see Table 2). These results show that the Likert
scale used in the Q16 modification is a repeatable
and reliable questionnaire.
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The SPSS© statistical package (version 18.0) was
used to analyse the data collected.
In order to learn about the relationship between
the original Q16 questionnaire answers compared
to the modified Q16 answers, a descriptive analysis
was run with the SPSS program.
Considering the Likert scale scores: 1 (Strongly
disagree), 2 (Disagree), 3 (Neutral), 4 (Agree),
5 (Strongly agree) and the relationship with the
positive (yes) or negative (no) answer, the results
showed that when a person answered “Yes” , the
answer scored between 3 (Neutral), 4 (Agree)
and 5 (Strongly Agree). On the other hand, when

they answered “No”, the score tended towards 1
(Strongly disagree) or 2 (Disagree). Nonetheless,
a couple of cases (n = 2) showed an inverse behaviour. We can only speculate that perhaps these two
participants were distracted when they answered
the questionnaires.
The tendency shown in the results suggests that
the subjects may find it easier to use a Likert scale
with more answer options than if they are forced
to choose between one of two options, in this case
“Yes” or “No”.
As a result, taking these comparisons and the statistical analysis into account, it could be said that
the modified version of the Q16 questionnaire
provides a greater range of data to assess neurological symptoms.
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Comparison between binary (yes/no)
answers in the original Q16 and the
modified Q16 answers

table 2. Paired t test results
Paired differences
Mean

Std. deviation

Std. error mean

Pair 1 LiQ1 - LisecQ1

0.040

0.549

Pair 2 LiQ2 - LicsecQ2

0.070

Pair 3 LiQ3 - LicsecQ3

95% confidence interval of the difference

t

df

Sig.
(2-tailed)

Lower

Upper

0.055

-0.069

0.149

0.729

99

0.468

0.432

0.043

-0.016

0.156

1.619

99

0.109

-0.050

0.411

0.041

-0.132

0.032

-1.216

99

0.227

Pair 4 LiQ4 - LicsecQ4

-0.040

0.567

0.057

-0.153

0.073

-0.705

99

0.482

Pair 5 LiQ5 - LicsecQ5

0.010

0.577

0.058

-0.105

0.125

0.173

99

0.863

Pair 6 LiQ6 - LicsecQ6

-0.060

0.397

0.040

-0.139

0.019

-1.510

99

0.134

Pair 7 LiQ7 - LicsecQ7

-0.030

0.540

0.054

-0.137

0.077

-0.555

99

0.580

Pair 8 LiQ8 - LicsecQ8

0.090

0.514

0.051

-0.012

0.192

1.75

99

0.083

Pair 9 LiQ9 - LicsecQ9

0.070

0.590

0.059

-0.047

0.187

1.186

99

0.239

Pair 10 LiQ10 - LicsecQ10

0.060

0.633

0.063

-0.066

0.186

0.948

99

0.345

Pair 11 LiQ11 - LisecQ11

0.040

0.511

0.051

-0.061

0.141

0.783

99

0.436

Pair 12 LiQ12 - LicsecQ12

0.020

0.402

0.040

-0.060

0.100

0.498

99

0.620

Pair 13 LiQ13 - LicsecQ13

-0.030

0.332

0.033

-0.096

0.036

-0.904

99

0.368

Pair 14 LiQ14 - LicsecQ14

-0.010

0.522

0.052

-0.114

0.094

-0.192

99

0.849

Pair 15 LiQ15 - LicsecQ15

-0.110

0.490

0.049

-0.207

-0.013

-2.244

99

0.027

Pair 16 LiQ16 - LicsecQ16

-0.160

0.677

0.068

-0.294

-0.026

-2.362

99

0.020

Source: Own elaboration
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Discussion

Conclusions

Jiménez Barbosa, Í. A.; Khuu, S.; Ying Boon, M.

Considering the results from the modified Q16
and comparing those with the original (Lundberg,
1997), the Likert scale may be regarded as a good
tool for measuring and comparing symptoms reported on a series of questions statements or issues
with greater precision than is possible with a yes-no
type question and greater ease of evaluation than
is possible with an open- ended question (Shank,
P. and Bircher, J., 2009).

To use the Likert scale in the Q16 questionnaire
gives more proximity to the real answer that a
subject wants to give.

Forcing responses artificially into a “yes” or “no”
format only may reduce individual differences, fail
to indicate the strength (or weakness) of a belief,
introduce a systematic source of error, and coerce
subjects into a response that they did not originally
intend (Chandler and Patterson, 1976).
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Appendices A

Apéndice A t1
DATE OF COMPLETION__________________________ ID Number_____________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 – NUMBER 1
S cale
Nº

Statement

Strongly
disagree

1

I have a short memory

2

My relatives and/or friends have told me that I am forgetful

3

I forget activities that I consider important

4

I generally find it hard to get the meaning of the news, programs, or fiction series
that I watch on TV or listen to on the radio

5

I have problems with concentrating

6

I often feel irritated without any reason

7

I often feel depressed or sad without any particular reason

8

I have problems deciding to do activities I know I must do

9

I feel abnormally tired

10

Sometimes I feel an oppression of my chest

11

I have had a sudden sensation of falling down while standing or walking

12

I often have a painful tingling in some part of my body

13

I have problems with buttoning or unbuttoning my clothes

14

I feel that I have lost strength in my arms or legs

15

I feel that I have less sensitivity or a complete loss of sensitivity in some parts of my
arms or legs

16

I often wake up and then have problems getting back to sleep again
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Disagree

Neutral

Agree

Strongly
agree

DATE OF COMPLETION__________________________ ID Number_________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 –NUMBER 2
N°

Question

S cale
Y es

1

Do you have a short memory?

2

Have your relatives and/or friends have told you that you are forgetful?

3

Do you often forget activities that you consider important?

4

Do you generally find it hard to get the meaning of the news, programs, or fiction series that I watch on TV or listen to on the radio?

5

Do you have problems with concentrating?

6

Do you often feel irritated without any reason?

7

Do you often feel depressed or sad without any particular reason

8

Do you have problems deciding to do activities I know you must do?

9

Are you abnormally tired?

10

Do you sometimes feel an oppression of your chest?

11

Have you had a sudden sensation of falling down while standing or walking?

12

Do you often have a painful tingling in some part of your body?

13

Do you have problems with buttoning or unbuttoning your clothes

14

Do you feel that I have lost strength in my arms or legs?

15

Do you feel less sensitivity or a complete loss of sensitivity in some parts of your arms or legs?

16

Do you often wake up and then have problems getting back to sleep again?

No

Modificación del cuestionario de síntomas neurotóxicos (Q16)
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DATE OF COMPLETION__________________________ ID Number_____________
NEUROTOXIC SYMPTOMS QUESTIONNAIRE Q16 – NUMBER 3
SCALE
No

Statement

1

I have a short memory

2

My relatives and/or friends have told me that I am forgetful

3

I forget activities that I consider important

4

I generally find it hard to get the meaning of the news, programs, or fiction series that
I watch on TV or listen to on the radio

5

I have problems with concentrating

6

I often feel irritated without any reason

7

I often feel depressed or sad without any particular reason

8

I have problems deciding to do activities I know I must do

9

I feel abnormally tired

10

Sometimes I feel an oppression of my chest

11

I have had a sudden sensation of falling down while standing or walking

12

I often have a painful tingling in some part of my body

13

I have problems with buttoning or unbuttoning my clothes

14

I feel that I have lost strength in my arms or legs

15

I feel that I have less sensitivity or a complete loss of sensitivity in some parts of my
arms or legs

16

I often wake up and then have problems getting back to sleep again
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Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

Demographic information
Q1: Age (years):
 18 – 22  23 – 27
 28– 32
 33 – 37
 38– 42
 38-40
Q2: Gender:
 Male
 Female
Q3: Do you suffer from Diabetes?
 No
 Yes
Q4: Do you suffer from Hypertension?
 No
 Yes
Q5: Do you suffer from cancer?
 Yes
 No
Q6: Do you suffer from any neurological disease? Please if yes, state the
name of the disease.
 No
 Yes
Name of the disease:__________________________________
Q7: Do you suffer of anxiety or depression?
 No
 Yes
Q8: Do you smoke? if yes, answer question number 9
 No
 Yes

Q9-: How many cigarettes you smoke per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q10-: How many cigars you smoke per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q11: Do you drink alcohol? if yes, answer question number 13
 No
 Yes
Q12-: How many alcoholic drinks you drink per day?
 0-4
 5-9
 10-14
 15-19
 ≥ 20
Q13: Do you take medication? If yes, answer question number 15
 No
 Yes
Q14-: What it is for?
 Infections
 Diabetes
 Hypertension
 Allergies
 AINES
 Corticoids
 Other (Specify) _______________________

Modificación del cuestionario de síntomas neurotóxicos (Q16)
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Appendix B

DATE OF COMPLETION_______________________ID Number_______________
Baseline Survey

DEMOGRAPHIC AND GENERAL HEALTH INFORMATION: Please tell us some basic information about yourself
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